We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report World - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Jun 11, 2024

World - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Global Vaccine Market 2024

Vaccine Market Size

After four years of growth, the global vaccine market decreased by X% to $X in 2023. Over the period under review, consumption showed resilient growth. Over the period under review, the global market attained the maximum level at $X in 2022, and then dropped in the following year.

Vaccine Production

In value terms, vaccine production amounted to $X in 2023 estimated in export price. In general, production posted a strong increase. The pace of growth was the most pronounced in 2021 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2022 to 2023, global production growth remained at a lower figure.

Vaccine Exports

Exports

In 2023, shipments abroad of vaccines for human medicine decreased by X% to X tons, falling for the second consecutive year after two years of growth. Overall, exports, however, enjoyed a remarkable increase. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2022 to 2023, the growth of the global exports remained at a lower figure.

In value terms, vaccine exports skyrocketed to $X in 2023. Over the period under review, exports, however, continue to indicate a prominent increase. The pace of growth was the most pronounced in 2021 when exports increased by X%. As a result, the exports reached the peak of $X. From 2022 to 2023, the growth of the global exports remained at a lower figure.

Exports by Country

In 2023, Belgium (X tons) represented the major exporter of vaccines for human medicine, constituting X% of total exports. It was distantly followed by the United States (X tons), France (X tons) and Ireland (X tons), together generating a X% share of total exports. The following exporters - the Netherlands (X tons), India (X tons) and Poland (X tons) - together made up X% of total exports.

From 2012 to 2023, average annual rates of growth with regard to vaccine exports from Belgium stood at X%. At the same time, Poland (X%), the United States (X%), the Netherlands (X%) and Ireland (X%) displayed positive paces of growth. Moreover, Poland emerged as the fastest-growing exporter exported in the world, with a CAGR of X% from 2012-2023. India and France experienced a relatively flat trend pattern. Belgium (X p.p.) and Poland (X p.p.) significantly strengthened its position in terms of the global exports, while India, Ireland and France saw its share reduced by X%, X% and X% from 2012 to 2023, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Belgium ($X) remains the largest vaccine supplier worldwide, comprising X% of global exports. The second position in the ranking was taken by the United States ($X), with a X% share of global exports. It was followed by France, with a X% share.

In Belgium, vaccine exports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: the United States (X% per year) and France (X% per year).

Export Prices by Country

The average vaccine export price stood at $X per ton in 2023, surging by X% against the previous year. Overall, export price indicated a tangible expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, vaccine export price increased by X% against 2018 indices. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United States ($X,392 per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the Netherlands (X%), while the other global leaders experienced more modest paces of growth.

Vaccine Imports

Imports

In 2023, approx. X tons of vaccines for human medicine were imported worldwide; increasing by X% on the previous year. In general, imports continue to indicate a strong increase. The growth pace was the most rapid in 2021 when imports increased by X%. As a result, imports reached the peak of X tons. From 2022 to 2023, the growth of global imports failed to regain momentum.

In value terms, vaccine imports skyrocketed to $X in 2023. Over the period under review, imports continue to indicate prominent growth. The most prominent rate of growth was recorded in 2021 when imports increased by X%. As a result, imports reached the peak of $X. From 2022 to 2023, the growth of global imports failed to regain momentum.

Imports by Country

In 2023, Pakistan (X tons), distantly followed by Belgium (X tons) and Spain (X tons) were the major importers of vaccines for human medicine, together committing X% of total imports. The following importers - France (X tons), Canada (X tons), Germany (X tons), the Netherlands (X tons), the UK (X tons), Italy (X tons), Brazil (X tons), the United States (X tons), South Africa (X tons) and Bangladesh (X tons) - together made up X% of total imports.

From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Spain (with a CAGR of X%), while imports for the other global leaders experienced more modest paces of growth.

In value terms, the largest vaccine importing markets worldwide were Belgium ($X), Germany ($X) and the United States ($X), with a combined X% share of global imports. Spain, Brazil, Pakistan, the UK, Canada, France, Bangladesh, the Netherlands, Italy and South Africa lagged somewhat behind, together accounting for a further X%.

Spain, with a CAGR of X%, saw the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

The average vaccine import price stood at $X per ton in 2023, increasing by X% against the previous year. In general, import price indicated a buoyant expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, vaccine import price increased by X% against 2021 indices. The pace of growth appeared the most rapid in 2022 an increase of X% against the previous year. Over the period under review, average import prices hit record highs in 2023 and is likely to see gradual growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was the United States ($X,673 per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Bangladesh (X%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

This report provides an in-depth analysis of the global vaccine market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Company coverage:

Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Merck & Co., GlaxoSmithKline, Sanofi, Chongqing Zhifei Biological Products Co., CureVac N.V., Roche Holding AG, Seqirus, Serum Institute Of India, Sinovac, Sinopharm, Fiocruz, Grupo Insud, The Commonwealth Serum Laboratories, Shionogi & Co., Mitsubishi Tanabe Pharma Corp., IMV Inc., Medicago, Valneva

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. GLOBAL PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. GLOBAL IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. GLOBAL EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 537

This report provides an in-depth analysis of the vaccine market in Asia.

U.S. - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 610

This report provides an in-depth analysis of the vaccine market in the U.S..

China - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 697

This report provides an in-depth analysis of the vaccine market in China.

EU - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 592

This report provides an in-depth analysis of the vaccine market in the EU.

Free Data: Vaccines For Human Medicine - World
Table
Vaccines For Human Medicine - World - Table
Dashboard
Vaccines For Human Medicine - World - Dashboard
Report
Vaccines For Human Medicine - World - Report